Medical Chief Officer for Moderna, Dr. Paul Burton on Sunday said that the “reformulated” vaccine against the new variant might be expected to roll out at the beginning of the next year.
However, it remains unclear whether modern vaccines may protect an individual from the new variant dubbed Omicron which is considered to be highly contagious, and whether modernized sorts of vaccines will be needed to protect an individual from the new strain.
“We should know about the ability of the current vaccine to provide protection in the next couple of weeks, but the remarkable thing about the MRNA vaccines, Moderna platform is that we can move very fast,” Burton told BBC.
“If we have to make a brand new vaccine I think that’s going to be early 2022 before that’s really going to be available in large quantities,” Burton said.
Omicron, the new variant of coronavirus, was first spotted in South Africa and reported on Wednesday and it could have already spread to many countries worldwide, including the UK,